Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Apr;21(4):509–512. doi: 10.1128/jcm.21.4.509-512.1985

Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing.

V Bezjak
PMCID: PMC271707  PMID: 3988896

Abstract

Standardized, evenly dispersed hyphal suspensions served as the inoculum in a microtiter technique for amphotericin B antifungal susceptibility testing. Preliminary testing with six strains of Aspergillus fumigatus and A. flavus produced consistent and reproducible results at 30 degrees C over 24 h. The observed amphotericin B MICs required for hyphae (0.3 to 0.6 microgram/ml) were comparable to MICs required for conidia (0.16 to 0.6 microgram/ml). The results were evaluated and compared with previously published information.

Full text

PDF
509

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandsberg J. W., French M. E. In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B. Antimicrob Agents Chemother. 1972 Nov;2(5):402–404. doi: 10.1128/aac.2.5.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brinkmann F. Sekundäre Sensibilitätsänderung von Candida albicans gegen 5 Fluoro-cytosin (5 FC) in vitro. Vergleich von fünf Methoden im Hinblick auf Routineuntersuchungen. Z Hautkr. 1981 Oct 1;56(19):1255–1263. [PubMed] [Google Scholar]
  3. Carrizosa J., Levison M. E., Lawrence T., Kaye D. Cure of Aspergillus ustus endocarditis on a prosthetic valve. Arch Intern Med. 1974 Mar;133(3):486–490. [PubMed] [Google Scholar]
  4. Edwards J. E., Jr, Morrison J., Henderson D. K., Montgomerie J. Z. Combined effect of amphotericin B and rifampin on Candida species. Antimicrob Agents Chemother. 1980 Mar;17(3):484–487. doi: 10.1128/aac.17.3.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ellis N. S., Bartlett M. S., Smith J. W. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system. Am J Clin Pathol. 1979 Aug;72(2):194–198. doi: 10.1093/ajcp/72.2.194. [DOI] [PubMed] [Google Scholar]
  6. Fisher B. D., Armstrong D. Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine. Antimicrob Agents Chemother. 1977 Nov;12(5):614–617. doi: 10.1128/aac.12.5.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Granade T. C., Artis W. M. Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum. Antimicrob Agents Chemother. 1980 Apr;17(4):725–729. doi: 10.1128/aac.17.4.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holt R. J. Laboratory tests of antifungal drugs. J Clin Pathol. 1975 Oct;28(10):767–774. doi: 10.1136/jcp.28.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. IKEMOTO H. TREATMENT OF PULMONARY ASPERGILLOMA WITH AMPHOTERICIN B. Arch Intern Med. 1965 May;115:598–601. doi: 10.1001/archinte.1960.03860170080017. [DOI] [PubMed] [Google Scholar]
  10. Kitahara M., Seth V. K., Medoff G., Kobayashi G. S. Antimicrobial susceptibility testing of six clinical isolates of Aspergillus. Antimicrob Agents Chemother. 1976 Jun;9(6):908–914. doi: 10.1128/aac.9.6.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Marks M. I., Eickhoff T. C. Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) 1970;10:491–493. [PubMed] [Google Scholar]
  12. Mazens M. F., Andrews G. P., Bartlett R. C. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B. Antimicrob Agents Chemother. 1979 Mar;15(3):475–477. doi: 10.1128/aac.15.3.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Merz W. G., Fay D., Thumar B., Dixon D. Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J Clin Microbiol. 1984 Jan;19(1):54–56. doi: 10.1128/jcm.19.1.54-56.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Perfect J. R., Durack D. T. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. J Infect Dis. 1982 Sep;146(3):429–435. doi: 10.1093/infdis/146.3.429. [DOI] [PubMed] [Google Scholar]
  15. Sandhu D. K., Doodani A., Singh D. Fungi associated with human corneal ulcers. Mykosen. 1980 May;23(5):269–273. [PubMed] [Google Scholar]
  16. Utz C. J., White S., Shadomy S. New medium for in vitro susceptibility studies with amphotericin B. Antimicrob Agents Chemother. 1976 Oct;10(4):776–777. doi: 10.1128/aac.10.4.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wagner G., Shadomy S., Paxton L. D., Espinel-Ingroff A. New method for susceptibility testing with antifungal agents. Antimicrob Agents Chemother. 1975 Jul;8(1):107–109. doi: 10.1128/aac.8.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES